These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1786081)

  • 1. Superantigens and Kawasaki disease.
    Furukawa S; Matsubara T; Yabuta K
    Immunol Today; 1991 Dec; 12(12):464. PubMed ID: 1786081
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum anti-Yersinia antibody in Chinese patients with Kawasaki disease.
    Chou CT; Chang JS; Ooi SE; Huo AP; Chang SJ; Chang HN; Tsai CY
    Arch Med Res; 2005; 36(1):14-8. PubMed ID: 15777989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigens, conventional antigens and the etiology of Kawasaki syndrome.
    Meissner HC; Leung DY
    Pediatr Infect Dis J; 2000 Feb; 19(2):91-4. PubMed ID: 10693992
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kawasaki disease: an infectious disease?].
    Cimaz R
    Rev Med Interne; 2005 Oct; 26 Spec No 1():15-8. PubMed ID: 16475258
    [No Abstract]   [Full Text] [Related]  

  • 5. Superantigens in dermatology.
    Macias ES; Pereira FA; Rietkerk W; Safai B
    J Am Acad Dermatol; 2011 Mar; 64(3):455-72; quiz 473-4. PubMed ID: 21315950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytopathogenic protein (CPP) produced by Propionibacterium acnes isolated from patients with Kawasaki disease.
    Tomita S; Koga Y; Inoue O; Fujimoto T; Kato H
    Prog Clin Biol Res; 1987; 250():73-80. PubMed ID: 3423083
    [No Abstract]   [Full Text] [Related]  

  • 7. Superantigens in the aetiology of Kawasaki disease.
    Fischer P; Uttenreuther-Fischer MM; Gaedicke G
    Lancet; 1996 Jul; 348(9021):202. PubMed ID: 8684184
    [No Abstract]   [Full Text] [Related]  

  • 8. Tat and Kawasaki disease.
    Rautonen J; Rautonen N
    Immunol Today; 1992 May; 13(5):190-1. PubMed ID: 1642759
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphocyte abnormalities and complement activation in Kawasaki disease.
    Laxer RM; Schaffer FM; Myones BL; Yount WJ; Rowe RD; Rubin L; Stein LD; Gelfand EW; Silverman ED
    Prog Clin Biol Res; 1987; 250():175-84. PubMed ID: 3423037
    [No Abstract]   [Full Text] [Related]  

  • 10. [Kawasaki mucocutaneous lymph node syndrome. 3 cases].
    Estavoyer JM; Boichard D; Folschweiller B; Baufle GH; Debrand J; Perat R
    Nouv Presse Med; 1979 Sep; 8(36):2908. PubMed ID: 493102
    [No Abstract]   [Full Text] [Related]  

  • 11. The pathogenesis of Kawasaki disease and superantigens.
    Uchiyama T; Kato H
    Jpn J Infect Dis; 1999 Aug; 52(4):141-5. PubMed ID: 10592892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current viewpoints in the pathogenesis of Kawasaki disease].
    Bollen CW; Rijkers GT; Zegers BJ; de Graeff-Meeder ER
    Ned Tijdschr Geneeskd; 1995 Mar; 139(11):549-54. PubMed ID: 7700390
    [No Abstract]   [Full Text] [Related]  

  • 13. Kawasaki syndrome: role of superantigens revisited.
    Leung DYM; Schlievert PM
    FEBS J; 2021 Mar; 288(6):1771-1777. PubMed ID: 32770775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro Lymphocyte response to mite antigen in Kawasaki disease (MCLS)].
    Hirota T; Kimoto K; Furusho K
    Arerugi; 1982 Oct; 31(10):1070-3. PubMed ID: 7168650
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of serum antibody by the antimitogen assay against streptococcal erythrogenic toxins. Age distribution in children and the relation to Kawasaki disease.
    Abe Y; Nakano S; Nakahara T; Kamezawa Y; Kato I; Ushijima H; Yoshino K; Ito S; Noma S; Okitsu S
    Pediatr Res; 1990 Jan; 27(1):11-5. PubMed ID: 2404253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease.
    Leung DY; Meissner HC; Shulman ST; Mason WH; Gerber MA; Glode MP; Myones BL; Wheeler JG; Ruthazer R; Schlievert PM
    J Pediatr; 2002 Jun; 140(6):742-6. PubMed ID: 12072880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complex study of biopsy specimens from Kawasaki disease patients.
    Fujimoto T; Kato H; Inoue O; Tomita S; Koga Y
    Prog Clin Biol Res; 1987; 250():209-17. PubMed ID: 3321077
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease.
    Gupta-Malhotra M; Viteri-Jackson A; Thomas W; Zabriskie JB
    Exp Mol Pathol; 2004 Apr; 76(2):117-21. PubMed ID: 15010289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of plasma exchange therapy for Kawasaki disease by cytokine profiling.
    Kashiwagi Y; Kawashima H; Akamatsu N; Morishima Y; Nishimata S
    Ther Apher Dial; 2012 Jun; 16(3):281-3. PubMed ID: 22607573
    [No Abstract]   [Full Text] [Related]  

  • 20. The etiology of Kawasaki disease: superantigen or conventional antigen?
    Rowley AH
    Pediatr Infect Dis J; 1999 Jan; 18(1):69-70. PubMed ID: 9951986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.